Results showed that at T0 all patients and controls presented similar MN frequencies, at T12 (12 weeks after the administration of treatments), both “acitretin + NBUVB” and “acitretin + PUVA” showed a trend towards an increase in MN frequency; however, only “acitretin + PUVA” reached a significant higher MN frequency.
← all excerpts
Genotoxic Effect in Autoimmune Diseases Evaluated by the Micronucleus Test Assay: Our Experience and Literature Review.
1
—
—